As of 2026-09-11, the Relative Valuation of Transgene SA (TNG.PA) is (6.12) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 EUR, the upside of Transgene SA based on Relative Valuation is -794.2%.
The range of the Relative Valuation is (4.05) - (5.72) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.0x - 60.9x | 60.1x |
| Forward P/E multiples | 20.7x - 42.4x | 30.8x |
| Fair Price | (4.05) - (5.72) | (6.12) |
| Upside | -558.8% - -748.2% | -794.2% |
| Date | P/E |
| 2026-09-08 | -6.56 |
| 2026-09-07 | -6.68 |
| 2026-09-04 | -6.40 |
| 2026-09-03 | -6.57 |
| 2026-09-02 | -5.84 |
| 2026-09-01 | -5.86 |
| 2026-08-31 | -5.93 |
| 2026-08-28 | -5.95 |
| 2026-08-27 | -5.99 |
| 2026-08-26 | -6.02 |
| 2026-08-25 | -5.98 |
| 2026-08-24 | -5.99 |
| 2026-08-21 | -6.00 |
| 2026-08-20 | -6.22 |
| 2026-08-19 | -6.24 |
| 2026-08-18 | -5.41 |
| 2026-08-17 | -5.39 |
| 2026-08-14 | -5.34 |
| 2026-08-13 | -5.34 |
| 2026-08-12 | -5.32 |
| 2026-08-11 | -5.28 |
| 2026-08-10 | -5.36 |
| 2026-08-07 | -5.26 |
| 2026-08-06 | -5.24 |
| 2026-08-05 | -5.26 |
| 2026-08-04 | -5.25 |
| 2026-08-03 | -5.29 |
| 2026-07-31 | -5.28 |
| 2026-07-30 | -5.29 |
| 2026-07-29 | -5.32 |
| 2026-07-28 | -5.33 |
| 2026-07-27 | -5.35 |
| 2026-07-24 | -5.37 |
| 2026-07-23 | -5.37 |
| 2026-07-22 | -5.40 |
| 2026-07-21 | -5.43 |
| 2026-07-20 | -5.45 |
| 2026-07-17 | -5.47 |
| 2026-07-16 | -5.43 |
| 2026-07-15 | -5.49 |
| 2026-07-14 | -5.52 |
| 2026-07-13 | -5.60 |
| 2026-07-10 | -5.62 |
| 2026-07-09 | -5.52 |
| 2026-07-08 | -5.57 |
| 2026-07-07 | -5.73 |
| 2026-07-06 | -5.75 |
| 2026-07-03 | -5.60 |
| 2026-07-02 | -5.40 |
| 2026-07-01 | -5.41 |